CTRI/2018/10/016039
Not yet recruiting
未知
An Exploratory Study to Evaluate Surgical Outcome and Financial Burden in Patients Treated with 3D Printing Technology Assisted Surgery versus Conventional Surgery for Facial Fractures at Level 1 Trauma Centre, AIIMS, New Delhi.
All India Institute of Medical SciencesNew Delhi0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: V196- Unspecified pedal cyclist injuredin collision with other and unspecified motor vehicles in traffic accident
- Sponsor
- All India Institute of Medical SciencesNew Delhi
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Both male and females ,
- •2\.Age:18\-65 years
- •3\.GCS \> 13
- •4\.Secondary facial deformities
Exclusion Criteria
- •1\.Patient not giving informed consent
- •2\.GCS \< 13
- •3\.Fresh facial Injuries
- •4\.Evidence of infection with HIV/hepatitis B
- •5\.Pregnancy/Breastfeeding
- •6\.Underlying Systemic disorders
- •Patient on
- •ii.Immuno\-modulator drugs
- •iii.Blood thinners
- •iv.Anti\-Psychotic drugs
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A prospective observational study of the surgery for lung cancer in patients with low pulmonary functioPrimary lung cancer, Chronic Obstructive Lung Disease (COPD)JPRN-UMIN000013233Yokohama City University Medical Center152
Recruiting
Not Applicable
Prospective Study Evaluating The Treatment Outcomes For Localised Recurrent, Resectable Retroperitoneal LiposarcomaRetroperitoneal Liposarcoma (LPS)Cancer - Sarcoma (also see 'Bone') - soft tissueACTRN12624000554561Australia and New Zealand Sarcoma Association100
Not yet recruiting
Not Applicable
A study to compare success using wet and dry graft in ear surgeryHealth Condition 1: H66- Suppurative and unspecified otitismediaCTRI/2019/02/017654JLN MEDICAL COLLEGE
Not yet recruiting
Phase 3
A phase III randomized study evaluating surgery of residual disease in patients with metastatic gastro-intestinal stromal tumor responding to imatinib mesylateGastro-intestinal stromal tumour (GIST)Cancer - Other cancer typesACTRN12609000681257European Organisation for Research and Treatment of Cancer (EORTC)350
Not yet recruiting
Phase 3
A phase III randomized study evaluating surgery of residual disease in patients with metastatic gastro-intestinal stromal tumor responding to Imatinib mesylate.bowel wall cancerGIST1001799010017998NL-OMON32805European Organisation for Research in Treatment of Cancer (EORTC)60